| 000 | 01365 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250515051920.0 | ||
| 264 | 0 | _c20070130 | |
| 008 | 200701s 0 0 eng d | ||
| 022 | _a0003-4967 | ||
| 024 | 7 |
_a10.1136/ard.2006.055541 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVander Cruyssen, B | |
| 245 | 0 | 0 |
_aComparison of different outcome measures for psoriatic arthritis in patients treated with infliximab or placebo. _h[electronic resource] |
| 260 |
_bAnnals of the rheumatic diseases _cJan 2007 |
||
| 300 |
_a138-40 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Psoriatic _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHealth Status Indicators |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfliximab |
| 650 | 0 | 4 |
_aJoints _xpathology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aDe Keyser, F | |
| 700 | 1 | _aKruithof, E | |
| 700 | 1 | _aMielants, H | |
| 700 | 1 | _aVan den Bosch, F | |
| 773 | 0 |
_tAnnals of the rheumatic diseases _gvol. 66 _gno. 1 _gp. 138-40 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/ard.2006.055541 _zAvailable from publisher's website |
| 999 |
_c16746545 _d16746545 |
||